Literature DB >> 19921567

[Analysis of clinical characteristics of gastrointestinal cancer in Heilongjiang province, China 1998 to 2007].

Xiao-ming Zou1, Xi-shan Wang, Yun-long Li, Zheng-xi Jin, Da-xun Piao, Xiao-yang Li, Da-wei Huang, Wei-xin Liu, Jian-guo Zhang, Guo-li Zhang, Hao-min Zhang, Zhi-gang Yu, Jian Zhang, Dong Fan, Wei-ye Liu, Ying-wei Xue, Jun Xu.   

Abstract

OBJECTIVE: To provide basic information for epidemiological research of gastrointestinal (GI) malignant tumors.
METHODS: Data of GI cancer diagnosed in 15 hospitals of Heilongjiang province between January 1998 and December 2007 were analyzed retrospectively. The data mainly involved the age of onset, initial symptoms, pathological types, clinical staging and types of surgical procedure.
RESULTS: Gastric cancer was the most common type (45.8%) among the 33,540 GI cancer cases, then were rectal cancer (27.3%) and colon cancer (26.8%). Right colon cancer cases were more common than the left ones (1.3:1.0), particularly in people over 80 (2.1:1.0). Only 1.3% of colorectal cancer could be found in age under 30 years old. In patients aged 50 to 70, advanced gastric cancer accounted for 70.6%, advanced colon cancer 73.4% and advanced rectal cancer 72.4%. Well-moderately differentiated adenocarcinoma in early gastric cancer was 49.7%, early colon cancer 77.3% and rectal cancer 83.2%. Patients undergone radical excision in early gastric cancer accounted for 69.1%, advanced gastric cancer 79.9%, left colon cancer 91.9%, right colon cancer 83.9% and in rectal cancer for 88.3%.
CONCLUSIONS: People aged 50 to 70 tend to get GI cancer in Heilongjiang province. Gastric cancer is the most common GI cancer. Radical excision is the main choice of therapy.

Entities:  

Mesh:

Year:  2009        PMID: 19921567

Source DB:  PubMed          Journal:  Zhonghua Wei Chang Wai Ke Za Zhi        ISSN: 1671-0274


  1 in total

1.  A novel DNA methylation signature associated with lymph node metastasis status in early gastric cancer.

Authors:  Shang Chen; Yanqi Yu; Tao Li; Weimei Ruan; Jun Wang; Quanzhou Peng; Yingdian Yu; Tianfeng Cao; Wenyuan Xue; Xin Liu; Zhiwei Chen; Jiang Yu; Jian-Bing Fan
Journal:  Clin Epigenetics       Date:  2022-02-03       Impact factor: 6.551

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.